Top Trends Transforming the Point-of-Care (POC) Coagulation Testing Devices Market Landscape in 2025: Revolutionizing Coagulation Testing with Immunofluorescence-Based Quantitative Analysis

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Point-of-Care (POC) Coagulation Testing Devices Industry Market Size Be by 2025?
The market for point-of-care (PoC) coagulation testing devices has expanded significantly in the past several years. The size of the market is projected to increase from $2.12 billion in 2024 to $2.32 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The growth during the historic phase can be credited to the rising occurrences of infectious and chronic diseases, growth in the aged population, increased adoption of compact portable instruments, expanded use of biomarker profiling, and heightened demand for individualized medicine.

What's the Long-Term Growth Forecast for the Point-of-Care (POC) Coagulation Testing Devices Market Size Through 2029?
The market for point-of-care (POC) coagulation testing devices is set to witness a robust increase in size over the foroming years. It's projected to reach $3.27 billion by 2029, boasting a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this predicted growth in the upcoming period include a heightened need for swift and precise disease diagnosis, a stronger focus on wellness and preventative health, escalating demand for quick and onsite diagnostic testing, an increase in episodes of infectious disease, and the emergence of telemedicine. Future trends in the forecasted period are predicted to involve the integration of next-generation sequencing (NGS), RNA detection and analysis, single-cell PCR analysis, the usage of bioinformatics software and data analysis tools, microfluidic technologies, lab-on-a-chip systems, point-of-care testing (POCT), as well as the adoption of artificial intelligence (AI) and data analytics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-devices-global-market-report

What Are the Key Growth Drivers Fueling the Point-of-Care (POC) Coagulation Testing Devices Market Expansion?
The increasing rate of blood clotting disorders is projected to fuel the development of the point-of-care (POC) coagulation testing devices market. Blood clotting disorders hinder the blood's capacity to clot effectively. Lifestyle attributes like smoking, excessive intake of alcohol, and sedentism may lead to blood clotting disorders by negatively impacting the health of blood vessels, altering levels of clotting factors, and inhibiting proper blood flow, thus raising the likelihood of unusual clot formation. POC coagulation testing devices allow medical professionals to promptly evaluate a patient's coagulation status, facilitating immediate alterations to medication and treatment plans. For example, as per the World Federation of Hemophilia's global survey in October 2023, a Canadian international non-profit organization, in 2022, a population of 427,685 was afflicted with bleeding disorders. Out of these, 257,146 were diagnosed with hemophilia, including 208,957 with Hemophilia A, 42,203 with Hemophilia B, and 5,986 with an unidentified type of hemophilia. Furthermore, 70,034 individuals were detected with other bleeding disorders. Consequently, the uptick in the incidence of blood clotting disorders propels the growth of the point-of-care (POC) coagulation testing devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15636&type=smp

What Are the Key Trends Driving Point-of-Care (POC) Coagulation Testing Devices Market Growth?
Major firms in the point-of-care (POC) coagulation testing devices market are focusing on the production of immunofluorescence-based quantitative analyzers to advance the identification and treatment of coagulation issues. These diagnostic devices use immunofluorescence to accurately measure and quantify specific proteins or molecules involved in coagulation, which are vital in diagnosing and managing blood clot disorders. For example, in January 2023, an India-based firm, Cipla Limited, introduced Cippoint, an immunofluorescence-based quantitative analyzer. It makes use of immunofluorescence technology to deliver swift and precise test results within a timeframe of 3 to 15 minutes, thereby accelerating the process of clinical decisions. Cippoint plays an instrumental role in improving diagnostic efficiency with its easy-to-use interface, fast result generation, and broad testing capabilities. Moreover, it encourages prompt clinical decisions and enhances patient care outcomes.

How Is the Point-of-Care (POC) Coagulation Testing Devices Market Segmented?
The point-of-care (poc) coagulation testing devices market covered in this report is segmented -

1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Blood Gas And Electrolyte Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users

Subsegments:
1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors
2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles
3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15636&type=smp

Which Companies Are Leading the Charge in Point-of-Care (POC) Coagulation Testing Devices Market Innovation?
Major companies operating in the point-of-care (POC) coagulation testing devices market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips N.V., Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, Sonora Quest Laboratories, 23andMe Holding Co, Thorne HealthTech Inc., Metropolis Healare Limited, Color Health Inc., LetsGetChecked Inc., Ambry Genetics Corporation, MyHeritage Ltd., Genova Diagnostics Inc., Everlywell Inc., Complete Genomics Incorporated, DanteLabs Inc., HemoSonics LLC, Gene by Gene Ltd., Veritas Intercontinental, DirectLabs LLC, Full Genomes Corporation Inc., Ulta Lab Tests LLC, WellnessFX Inc., Any Lab Test Now Inc.

Which Regions Are Leading the Global Point-of-Care (POC) Coagulation Testing Devices Market in Revenue?
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2024. The regions covered in the point-of-care (POC) coagulation testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15636

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.